Bifidobacterium Lactis B420 and Body Fat: What the Trial Shows

Bifidobacterium animalis subsp. lactis 420 — sold as "B420" — is the rare weight-management probiotic that was tested in a properly sized, six-month randomized trial. That alone puts it ahead of most "metabolic" probiotics, which lean on tiny studies or animal data. The trial found that B420 reduced body fat. But the honest version of that headline has an asterisk worth understanding before you buy anything: the clean statistical win came from a post-hoc (after-the-fact) analysis, not the trial's pre-specified primary outcome.

The trial: 225 adults, six months, four groups

The pivotal study (Stenman and colleagues, 2016) randomized 225 overweight and obese but otherwise healthy adults to one of four daily treatments for six months: placebo (microcrystalline cellulose), the prebiotic fiber Litesse (polydextrose) alone, B420 alone, or B420 plus the fiber ¹. The design is exactly what you want: adequately powered, double-blind, and long enough to see body-composition change rather than just a marker blip.

Here's the nuance. In the trial's primary (intention-to-treat) analysis, B420 alone reduced relative body fat mass by about 3% versus placebo, but that did not reach statistical significance (P=0.28). In a per-protocol/post-hoc analysis — restricted to people who actually completed the protocol — B420 reduced body fat mass by about 4% versus placebo, and that was significant (P=0.002) ¹. The reductions were most pronounced in the abdominal region, and a smaller waist measurement accompanied the fat-mass change. A post-hoc significant result is a real signal, but it sits a notch below a pre-planned primary endpoint — it's the kind of finding that earns a moderate, not strong, grade and ideally wants independent replication.

Did the fiber help? Read this carefully

The product is often marketed as "best with prebiotic fiber," and the synergy story is biologically reasonable — but this particular trial doesn't cleanly prove it. Fiber (polydextrose) alone did not reduce body fat in the study, and adding fiber to B420 did not clearly beat B420 on its own for the fat-mass outcome ¹. So the honest read is: B420 carried the effect here, and the prebiotic-pairing benefit is more a mechanistic expectation than a result this trial demonstrated. A separate randomized study of the same probiotic-and-fiber approach in overweight adults found it altered the gut microbiota and metabolism, supporting the mechanism without overturning the modest body-composition picture ².

The Akkermansia and metabolic mechanism — mostly from mice

Why might B420 affect fat at all? The mechanistic work points toward the gut barrier and a now-famous "good" bacterium, Akkermansia muciniphila. In an obesogenic mouse model, polydextrose with or without B420 increased the prevalence of Akkermansia and improved liver health ³, and in diabetic mice B420 plus polydextrose improved the efficacy of antidiabetic drugs ⁴. Akkermansia itself has real — if early — human metabolic credentials: a proof-of-concept study in overweight and obese volunteers found supplementing with it improved several metabolic markers ⁵. (We cover that strain in depth in Akkermansia and metabolic health.) The throughline is gut-barrier integrity: the B420 trial linked its fat-mass effect to serum zonulin, a marker of intestinal permeability ¹. That's a coherent story — but note the Akkermansia/liver and drug-efficacy pieces are rodent data, and rodent metabolism translates to humans inconsistently.

The strain-specificity rule still applies

As with every probiotic, the evidence is for one defined strain at one dose — B. animalis subsp. lactis 420 at 10^10 CFU/day. A bottle that lists only "Bifidobacterium lactis" (a common species in countless yogurts and blends) is not the studied product. This is exactly why the category-wide meta-analysis of probiotics for weight finds only a small average effect of about −0.6 kg: it pools many strains, most of which aren't B420 ⁶. Buy the strain code, or you're paying for the marketing, not the trial. We keep that discipline across our best probiotics for weight loss review, the best metabolic probiotic hub, and the graded strain table for women's probiotics, where B420 sits alongside the other strains with real human data.

Safety and honest expectations

For most healthy people, B420 is well tolerated. The general probiotic-safety caveat applies — rare bloodstream infections are documented in immunocompromised or critically ill patients, so anyone with a serious medical condition should consult a clinician first ⁷. As for expectations: a ~4% reduction in body fat mass over six months (in the favorable analysis) is a genuine, useful nudge, but it is not dramatic weight loss and it is dwarfed by what GLP-1 medications achieve. The stronger metabolic lever remains fermentable fiber feeding your whole microbial community, which we explain in our pillar on the gut–metabolism connection, and the broader probiotic picture is in do probiotics help weight and metabolism?. For where the prebiotic-plus-probiotic logic does and doesn't hold up, see prebiotics vs probiotics vs postbiotics.

The honest bottom line

B420 is one of the better-evidenced weight-management probiotics: a real, six-month, 225-person randomized trial showing a roughly 4% reduction in body fat mass. The catch is that the clean statistical win was a post-hoc analysis rather than the pre-specified primary outcome, the prebiotic-fiber "synergy" wasn't actually demonstrated for fat loss in that trial, and much of the supporting mechanism is mouse data. Treat B420 as a modest, strain-specific tool — buy the exact strain and dose, keep expectations realistic, and build it on top of a fiber-rich diet rather than in place of one.